Tecvayli global sales 2023?

I don’t have the exact 2023 global net sales figure for Tecvayli (talquetamab) memorized. Tecvayli is a Janssen/Genmab product that began commercial sales in 2023, and the precise full-year 2023 sales are reported in Genmab’s and Janssen’s investor materials.

If you want to get the exact number, here’s where to look:
- Genmab A/S 2023 annual report / 2023 Form 20-F (search for “Tecvayli” or “talquetamab” in the product sales section).
- Genmab press releases covering full-year 2023 results (they usually include a table showing sales by product).
- Janssen investor materials for 2023 (earnings releases or annual reports often break out product sales by key therapies).

If you’d like, I can guide you step-by-step to locate the exact line item or help interpret the figure once you have it.